Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lifesaving operations at risk say US surgeons

This article was originally published in Clinica

Executive Summary

US surgeons have warned that they will be forced to stop performing accepted lifesaving procedures and instead use only "approved" - but more invasive, dangerous and costly - surgical techniques. At issue is a year-long US Department of Justice/Department of Health & Human Services Inspector General investigation into hospital billings for use of unapproved cardiac devices. The Justice Department issued 125 subpoenas last June, alleging that institutions charged Medicare and Medicaid programmes for these products even though US law forbids reimbursement until the devices are approved.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT091760

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel